Clinical Trial Update: Influence of Valproic Acid on Extinction-based Therapy in Patients With Fear of Spiders. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating the influence of valproic acid on extinction-based therapy for specific phobia (fear of spiders) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Specific Phobia

Drugs mentioned

• VALPROIC ACID (Valproic acid)

Snippet

Sponsor: Prof. Dominique de Quervain, MD | Conditions: Phobia, Specific | Phase 2 | Status: COMPLETED